ACHE and Alzheimer disease: Although not here tested, it could be speculated that 9-methylfascaplysin might inhibit acetylcholinesterase activity and induce P-glycoprotein, as fascaplysin does, which would make fascaplysin derivatives a class of potential multiple-target anti-AD drugs [12].